CCT6A, a novel prognostic biomarker for Ewing sarcoma
| Autor: | Zequn Wang, Tuo Liang, Zhaojun Lu, Jiarui Chen, Chong Liu, Shian Liao, Guoyong Xu, Hao Li, Xinli Zhan, Tianyou Chen, Chaojie Yu, Zide Zhang, Jie Jiang |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Adolescent overall survival Bone Neoplasms event-free survival Sarcoma Ewing CCT6A Young Adult 03 medical and health sciences 0302 clinical medicine Databases Genetic Biomarkers Tumor Humans Medicine 030212 general & internal medicine Progression-free survival Child Survival analysis Proportional Hazards Models Regulation of gene expression champeronin containing TCP1 complex 6A gene business.industry Proportional hazards model Age Factors General Medicine medicine.disease Progression-Free Survival Gene Expression Regulation 030220 oncology & carcinogenesis Cancer research biomarker Immunohistochemistry Biomarker (medicine) Female prognosis Sarcoma business Systematic Review and Meta-Analysis Ewing sarcoma Chaperonin Containing TCP-1 Research Article |
| Zdroj: | Medicine |
| ISSN: | 1536-5964 0025-7974 |
| Popis: | Background: Ewing sarcoma (ES), the second most prevalent bone malignant tumor has no widely known prognostic biomarker. Earlier studies have suggested that chaperonin containing TCP1 complex 6A (CCT6A), which encodes a molecular protein chaperone, is involved in the pathogenesis of many cancers. However, there are no known reports providing clear evidence of its role in ES pathogenesis. Methods: We performed a bioinformatic analysis of 32 ES specimens from the GSE17618 dataset concentrating on the differences in gene expression, OS, event-free survival (EFS) in the different subgroups. Immunohistochemical studies were also performed to identify the expression levels of selected genes in ES and immediate paracancerous tissues. Results: After 3 screenings, CCT6A was identified to be highly correlated with ES prognosis. Our survival analysis revealed a low overall survival (OS) for high CCT6A expression (P-value = .024). Our Cox regression analysis identified CCT6A expression, lEFS, and age were strongly associated with prognosis of ES. Our multivariate Cox regression analysis shows that CCT6A (P-value = .015), age (P-value = .026), and EFS (P-value = .002) were independent poor prognostic biomarkers. Our immunohistochemical analysis showed that the expression levels of CCT6A were significantly higher in ES tissues compared to the paracancerous tissues. Conclusion: From the results of our study, we identified the expression levels of CCT6A to be strongly associated with prognosis of ES. Thus, the expression levels of the CCT6A gene could serve as a biomarker for the prediction of ES prognosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|